Egg Drop Syndrome 1976 (EDS-76) Caused by Duck Adenovirus A (DAdV-A)

Egg Drop Syndrome 1976 (EDS-76) is a highly contagious viral disease of commercial laying hens and broiler breeders, characterized by a sudden and dramatic drop in egg production, the production of soft-shelled, shell-less, or thin-shelled eggs, and a transient deterioration in egg internal quality. The disease is caused by Duck Adenovirus A (DAdV-A), a member of the genus Atadenovirus within the family Adenoviridae. EDS-76 is of significant economic importance to the poultry industry worldwide, particularly in intensive layer and breeder operations, where it can cause production losses of up to 40% and severe economic impact due to the loss of marketable eggs. The disease primarily affects chickens (Gallus gallus domesticus), but natural and experimental infections have been reported in other avian species, including ducks, geese, and turkeys. The virus is transmitted both vertically (transovarian) and horizontally, with the primary reservoir being waterfowl, particularly ducks, which often show no clinical signs. In commercial poultry, the disease typically manifests during the peak of egg production, usually between 25 and 35 weeks of age, and can persist for several weeks, leading to prolonged economic losses. The disease is classified as a notifiable disease in some countries, and its control relies on strict biosecurity, vaccination, and the use of specific-pathogen-free (SPF) flocks for breeding stock.

The causative agent of Egg Drop Syndrome 1976 is Duck Adenovirus A (DAdV-A), also known as Egg Drop Syndrome virus (EDSV). It is a non-enveloped, icosahedral virus with a double-stranded DNA genome of approximately 33-34 kilobase pairs. The virus belongs to the genus Atadenovirus, which is characterized by a unique genomic organization and a narrow host range. The viral capsid is composed of 240 hexon capsomeres and 12 penton capsomeres, with penton fibers projecting from each vertex. The hexon protein is the major structural protein and contains type-specific and group-specific antigenic determinants. The virus hemagglutinates chicken, duck, and goose erythrocytes, a property that is utilized in the hemagglutination inhibition (HI) test for serological diagnosis. The virus is resistant to environmental conditions, including heat (56°C for 30 minutes), pH extremes (pH 3-10), and many common disinfectants, but is inactivated by formalin, glutaraldehyde, and chlorine-based disinfectants. There is only one serotype of EDSV, and it is antigenically distinct from other avian adenoviruses, including Fowl Adenovirus (FAdV) and Turkey Adenovirus. The virus replicates in the nucleus of infected cells, where it forms characteristic intranuclear inclusion bodies. The virus has a predilection for the reproductive tract, particularly the shell gland (uterus) of laying hens, where it causes necrosis and inflammation, leading to the production of abnormal eggs.

EDS-76 is distributed worldwide, with a higher prevalence in countries with intensive poultry production. The disease primarily affects commercial laying hens and broiler breeders, with peak incidence occurring during the peak of egg production (25-35 weeks of age). The virus is transmitted both vertically and horizontally. Vertical transmission occurs through the transovarian route, where the virus is present in the embryo and hatched chicks, which may shed the virus later in life, particularly at the onset of egg production. Horizontal transmission occurs through direct contact with infected birds, contaminated equipment, feed, water, and litter, as well as through the use of contaminated vaccines (e.g., live vaccines prepared in duck embryo fibroblasts). The primary reservoir of the virus is waterfowl, particularly ducks and geese, which often show no clinical signs but shed the virus in their feces. Wild birds, such as mallards, can also serve as carriers and introduce the virus into poultry flocks. The disease is more common in multi-age layer complexes and in flocks with poor biosecurity. The morbidity rate can reach 100% in susceptible flocks, while the mortality rate is typically low (less than 1%), but can be higher in cases of secondary bacterial infections. The economic impact is primarily due to the drop in egg production, which can be as high as 40%, and the production of unmarketable eggs. The feed conversion ratio (FCR) is adversely affected, as birds continue to consume feed but produce fewer and lower-quality eggs. The disease can also cause a transient decrease in egg weight and an increase in the number of cracked and soft-shelled eggs.

The pathogenesis of EDS-76 begins with the entry of the virus through the respiratory or oral route, followed by primary replication in the upper respiratory tract and the intestinal epithelium. The virus then spreads via the bloodstream to target organs, particularly the reproductive tract. The virus has a strong tropism for the shell gland (uterus) of the oviduct, where it replicates in the epithelial cells lining the glandular tissue. The replication of the virus in the shell gland leads to necrosis and desquamation of the epithelial cells, resulting in a severe inflammatory response. This inflammation disrupts the normal function of the shell gland, leading to the production of eggs with abnormal shells, including soft-shelled, shell-less, and thin-shelled eggs. The virus also affects the albumen-secreting glands of the magnum, leading to a decrease in the quality of the egg white, which becomes watery and less viscous. The virus can also replicate in the intestinal epithelium, causing mild enteritis, and in the spleen and liver, leading to mild lymphoid depletion and hepatocyte degeneration. The virus does not typically cause systemic disease or high mortality, but the local damage to the reproductive tract is sufficient to cause significant economic losses. The virus induces a humoral immune response, with the production of neutralizing and hemagglutination-inhibiting antibodies, which can be detected by serological tests. The immune response, however, does not prevent the shedding of the virus, and infected birds can become carriers and shed the virus intermittently.

Several intrinsic and extrinsic factors predispose flocks to EDS-76. Intrinsic factors include the genetic strain of the bird, with some commercial layer strains being more susceptible than others. The age of the bird is critical, as the disease typically manifests during the peak of egg production, when the reproductive tract is under maximal physiological stress. High production stress, such as that seen in high-producing layers, can exacerbate the severity of the disease. The immune status of the flock is also important; flocks with inadequate immunity due to poor vaccination or immunosuppressive diseases (e.g., Infectious Bursal Disease, Marek's Disease) are more susceptible. Extrinsic factors include poor biosecurity, which allows the introduction of the virus through contaminated equipment, personnel, or wild birds. High stocking density and poor ventilation can increase the concentration of the virus in the environment and facilitate horizontal transmission. Wet litter and poor sanitation provide a favorable environment for the survival of the virus. The use of contaminated vaccines, particularly live vaccines prepared in duck embryo fibroblasts, has been a significant source of infection in the past. Feed contamination with the virus through contaminated feed ingredients (e.g., poultry by-products) can also introduce the virus into a flock. Vaccination failure, due to improper vaccine storage, administration, or the use of vaccines that do not match the circulating strain, can leave flocks susceptible.

The clinical signs of EDS-76 are primarily observed in laying hens and broiler breeders, typically at the peak of egg production. The first sign is often a sudden drop in egg production, which can be as high as 40% within a few days. The drop is accompanied by the production of abnormal eggs, including soft-shelled, shell-less, and thin-shelled eggs. The eggs may also have pale shells, rough shells, or a loss of shell pigment. The internal quality of the eggs is also affected, with the albumen becoming watery and less viscous. The birds may appear clinically normal, with no obvious signs of systemic illness, but some birds may show mild depression, anorexia, and a slight pallor of the comb and wattles. In some cases, there may be a transient diarrhea, with the feces being pasty and yellowish. The disease does not typically cause respiratory signs, but mild rales may be heard in some birds. The egg production drop lasts for 4 to 10 weeks, after which production gradually recovers, but it may not return to the pre-infection level. The recovery is often incomplete, with a permanent reduction in total egg production of 5-10%. The mortality rate is usually low, but secondary bacterial infections, such as colibacillosis, can increase mortality. In broiler breeders, the disease can also cause a decrease in hatchability due to the production of abnormal eggs.

The differential diagnoses for EDS-76 include several other viral and bacterial diseases that cause a drop in egg production and abnormal eggs. These include: 1) Infectious Bronchitis (IB): Caused by the coronavirus, IB causes respiratory signs, a drop in egg production, and the production of soft-shelled and misshapen eggs. However, IB also causes respiratory distress, tracheal rales, and nephritis in some strains. The diagnosis is confirmed by virus isolation, RT-PCR, and serology (ELISA, HI). 2) Newcastle Disease (ND): Caused by the avian paramyxovirus type 1, ND causes respiratory, nervous, and digestive signs, along with a drop in egg production. The eggs may be soft-shelled, but the disease is more severe, with high mortality in unvaccinated flocks. Diagnosis is by virus isolation, RT-PCR, and HI test. 3) Avian Influenza (AI): Caused by type A influenza viruses, AI can cause a drop in egg production, respiratory signs, and high mortality in highly pathogenic forms. The eggs may be abnormal, but the disease is often more severe. Diagnosis is by virus isolation, RT-PCR, and AGID. 4) Mycoplasma gallisepticum (MG) Infection: MG causes respiratory signs, airsacculitis, and a drop in egg production. The eggs may be normal in shell quality, but the disease is chronic. Diagnosis is by serology (plate agglutination, HI, ELISA) and PCR. 5) Egg Drop Syndrome due to other adenoviruses: Other avian adenoviruses, such as Fowl Adenovirus (FAdV), can cause a drop in egg production, but they are less commonly associated with shell abnormalities. Diagnosis is by virus isolation and serology. 6) Nutritional deficiencies: Deficiencies in calcium, vitamin D3, or phosphorus can cause shell quality problems, but they are not associated with a sudden drop in production. Diagnosis is by feed analysis and response to supplementation. 7) Management stress: Stressors such as sudden changes in feed, water, lighting, or temperature can cause a temporary drop in egg production, but the eggs are usually normal. Diagnosis is by history and exclusion of infectious causes.

The diagnostic algorithm for EDS-76 begins with a thorough flock history, including age, vaccination status, production records, and recent changes in management. Clinical signs, particularly a sudden drop in egg production and the presence of abnormal eggs, are highly suggestive. A complete necropsy of affected birds should be performed, with particular attention to the reproductive tract. Gross lesions may include a pale, flaccid, and edematous shell gland, with a catarrhal exudate. The ovary may show regressed follicles. Histopathology of the shell gland reveals necrosis and desquamation of the epithelial cells, with intranuclear inclusion bodies. For laboratory confirmation, the following steps are recommended: 1) Serology: Collect serum samples from affected birds and test for antibodies to EDSV using the Hemagglutination Inhibition (HI) test or ELISA. A four-fold rise in antibody titers between acute and convalescent samples is diagnostic. 2) Virus isolation: Attempt to isolate the virus from the shell gland, oviduct, or feces of affected birds. The virus can be propagated in duck embryo fibroblasts or in embryonated duck eggs. 3) Molecular detection: Use PCR or real-time PCR to detect viral DNA in clinical samples. This is a rapid and sensitive method. 4) Histopathology: Examine tissue sections for characteristic intranuclear inclusion bodies in the shell gland epithelium. 5) Differential diagnosis: Rule out other causes of egg production drops, such as IB, ND, AI, and MG, using appropriate tests. The diagnostic algorithm should be followed in a stepwise manner, with the results of each test guiding the next step.

Laboratory findings in EDS-76 include: 1) Serology: The HI test is the most commonly used serological test. A titer of 1:16 or higher is considered positive. ELISA is also available and can be used for large-scale screening. In infected flocks, there is a significant increase in antibody titers, often reaching 1:128 or higher. 2) Molecular diagnostics: PCR and real-time PCR are highly sensitive and specific for the detection of EDSV DNA in clinical samples, such as shell gland tissue, oviduct swabs, and feces. The PCR can be performed using primers specific for the hexon gene. 3) Virus isolation: The virus can be isolated in duck embryo fibroblasts or in embryonated duck eggs. The virus causes characteristic cytopathic effects, including cell rounding and detachment, and the formation of intranuclear inclusion bodies. 4) Histopathology: Microscopic examination of the shell gland reveals necrosis and desquamation of the epithelial cells, with the presence of basophilic intranuclear inclusion bodies. There is also an infiltration of mononuclear cells in the lamina propria. 5) Hematology and blood chemistry: There are no specific hematological changes, but there may be a mild leukocytosis. Blood calcium and phosphorus levels may be normal, but there may be a decrease in serum protein levels due to the loss of protein in the eggs. 6) Feed analysis: If nutritional deficiencies are suspected, feed samples should be analyzed for calcium, phosphorus, vitamin D3, and other essential nutrients.

Imaging modalities are not commonly used in the diagnosis of EDS-76, but they can be helpful in some cases. Radiography can be used to assess the skeletal system and detect any abnormalities, such as osteoporosis or rickets, which may be predisposing factors. However, radiography is not specific for EDS-76. Ultrasonography can be used to examine the reproductive tract, particularly the shell gland, and may reveal thickening of the glandular tissue or the presence of fluid. However, this is not a routine diagnostic tool in poultry practice. Gross necropsy photography is essential for documenting the lesions, particularly the appearance of the shell gland and the abnormal eggs. The shell gland may appear pale, flaccid, and edematous, with a catarrhal exudate. The ovary may show regressed follicles. These gross findings can be captured and used for diagnostic purposes.

The cytology and histopathology of EDS-76 are characterized by lesions in the reproductive tract, particularly the shell gland. On gross necropsy, the shell gland is often pale, flaccid, and edematous, with a catarrhal exudate. The mucosal surface may be congested and show petechial hemorrhages. The ovary may show regressed follicles, and the oviduct may be flaccid. Microscopically, the shell gland epithelium shows necrosis and desquamation, with the presence of basophilic intranuclear inclusion bodies in the epithelial cells. The inclusion bodies are large, eosinophilic to basophilic, and often fill the nucleus. There is an infiltration of mononuclear cells, including lymphocytes and plasma cells, in the lamina propria. The glandular tissue may show atrophy and fibrosis in chronic cases. The magnum may also show mild inflammation and a decrease in the number of albumen-secreting glands. The intestinal epithelium may show mild enteritis, with infiltration of mononuclear cells. The spleen and liver may show mild lymphoid depletion and hepatocyte degeneration. These histopathological findings are characteristic and can be used to confirm the diagnosis.

There is no specific antiviral treatment for EDS-76. The management of an outbreak focuses on supportive care and the prevention of secondary bacterial infections. The following measures are recommended: 1) Supportive therapy: Provide a balanced diet with adequate levels of calcium, phosphorus, and vitamin D3 to support eggshell quality. Supplement the feed or water with vitamins and electrolytes to reduce stress. 2) Antibiotics: To prevent secondary bacterial infections, particularly colibacillosis, administer broad-spectrum antibiotics in the drinking water or feed. Commonly used antibiotics include oxytetracycline (10-20 mg/kg body weight, or 100-200 g/ton of feed for 5-7 days), amoxicillin (10-20 mg/kg, or 100-200 g/ton for 5-7 days), and enrofloxacin (10 mg/kg, or 50-100 mg/L of drinking water for 3-5 days, where legal). The choice of antibiotic should be based on sensitivity testing. 3) Anti-inflammatory drugs: Non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin or flunixin meglumine may be used to reduce inflammation in the reproductive tract, but their use in laying hens is limited due to withdrawal times. 4) Vaccination: In the face of an outbreak, vaccination of the flock with an inactivated EDS-76 vaccine may be considered to boost immunity and reduce shedding. However, vaccination is more effective as a preventive measure. 5) Biosecurity: Implement strict biosecurity measures to prevent the spread of the virus to other flocks. This includes isolating the affected flock, disinfecting equipment and facilities, and controlling the movement of personnel and vehicles. 6) Depopulation: In severe cases, depopulation of the affected flock may be necessary to prevent the spread of the disease, especially in breeding flocks. This is particularly important if the flock is a primary breeder or if the disease is notifiable.

The prognosis for EDS-76 is generally good, with a low mortality rate. However, the economic impact can be significant due to the drop in egg production and the production of abnormal eggs. The egg production typically recovers within 4 to 10 weeks, but it may not return to the pre-infection level. The recovery is often incomplete, with a permanent reduction in total egg production of 5-10%. The eggshell quality may also remain impaired for a longer period, with an increased number of cracked and soft-shelled eggs. The long-term prognosis depends on the severity of the infection, the age of the flock, and the management practices. In flocks that are vaccinated, the prognosis is better, as the vaccine reduces the severity of the disease and the shedding of the virus. In unvaccinated flocks, the disease can cause significant economic losses. The prognosis is also influenced by the presence of secondary infections, which can increase mortality and prolong the recovery period. In breeding flocks, the prognosis is more guarded, as the disease can affect hatchability and the quality of day-old chicks.

Following an outbreak of EDS-76, a structured follow-up plan is essential to monitor the recovery of the flock and prevent future outbreaks. The following measures are recommended: 1) Serological monitoring: Collect serum samples from the flock at regular intervals (e.g., every 2-4 weeks) to monitor antibody titers. The titers should decline gradually after the infection, but a rise in titers may indicate a re-infection or reactivation of the virus. 2) Production monitoring: Continue to monitor egg production, eggshell quality, and egg internal quality. The production should gradually return to normal, but any persistent abnormalities should be investigated. 3) Cleaning and disinfection: After the flock is depopulated, thoroughly clean and disinfect the poultry house and equipment. Use disinfectants that are effective against adenoviruses, such as formaldehyde, glutaraldehyde, or chlorine-based disinfectants. Allow the house to remain empty for at least 2-3 weeks before restocking. 4) Litter management: Remove and properly dispose of litter from the affected flock. The litter may contain the virus and can be a source of infection for future flocks. 5) Vaccination program: Review and update the vaccination program for the next flock. Vaccination of pullets with an inactivated EDS-76 vaccine at 16-18 weeks of age is recommended in areas where the disease is endemic. 6) Biosecurity audit: Conduct a biosecurity audit to identify and correct any weaknesses in the biosecurity measures. This includes controlling the movement of personnel, vehicles, and equipment, and preventing contact with wild birds.

Clinical pearls: 1) A sudden drop in egg production with the production of soft-shelled and shell-less eggs in a flock of laying hens at peak production is highly suggestive of EDS-76. 2) The disease is often subclinical in ducks, which serve as a reservoir. Therefore, the introduction of new birds from a source with unknown EDS status should be avoided. 3) The HI test is a reliable and cost-effective method for serological diagnosis. A four-fold rise in titer between acute and convalescent samples is diagnostic. 4) The virus can be inactivated by formaldehyde and glutaraldehyde, so these disinfectants should be used for cleaning and disinfection. 5) Vaccination of pullets at 16-18 weeks of age with an inactivated vaccine is the most effective preventive measure. Pitfalls: 1) Misdiagnosis as Infectious Bronchitis or Newcastle Disease, which can lead to inappropriate treatment and control measures. 2) Failure to consider EDS-76 in flocks that have been vaccinated against IB and ND, as the clinical signs can be similar. 3) Overreliance on clinical signs alone, without laboratory confirmation, can lead to misdiagnosis. 4) Inadequate biosecurity measures can lead to the introduction and spread of the virus. 5) The use of live vaccines prepared in duck embryo fibroblasts can introduce the virus into a flock. Therefore, only vaccines from reputable sources should be used.

There is no specific antiviral treatment for EDS-76. The following protocols are recommended for supportive care and the prevention of secondary infections: 1) Antibiotics: Oxytetracycline: 10-20 mg/kg body weight, or 100-200 g/ton of feed, administered for 5-7 days. Amoxicillin: 10-20 mg/kg, or 100-200 g/ton of feed, for 5-7 days. Enrofloxacin: 10 mg/kg, or 50-100 mg/L of drinking water, for 3-5 days (where legal). Florfenicol: 20-30 mg/kg, or 200-300 g/ton of feed, for 5-7 days. The withdrawal times for eggs and meat must be observed according to local regulations. 2) Vitamins and electrolytes: Supplement the drinking water with a multivitamin solution containing vitamins A, D3, E, and C, as well as electrolytes, for 3-5 days to reduce stress and support the immune system. 3) Anti-inflammatory drugs: Aspirin (acetylsalicylic acid) can be administered at a dose of 50-100 mg/kg body weight in the drinking water for 1-2 days to reduce inflammation and fever. However, the use of NSAIDs in laying hens is limited due to the risk of drug residues in eggs. 4) Vaccination: Inactivated EDS-76 vaccines are available and are administered subcutaneously or intramuscularly to pullets at 16-18 weeks of age. The vaccine is usually combined with inactivated Newcastle Disease and Infectious Bronchitis vaccines. The vaccine should be administered according to the manufacturer's instructions, with a booster dose if necessary. 5) Disinfectants: For cleaning and disinfection, use formaldehyde (2-5% solution), glutaraldehyde (2% solution), or chlorine-based disinfectants (e.g., sodium hypochlorite at 500-1000 ppm). These should be used after thorough cleaning of the premises.

EDS-76 was first described in 1976 in the Netherlands, and since then, numerous studies have been conducted to understand the disease and its control. Key findings from the literature include: 1) The virus is a duck adenovirus, and waterfowl are the natural reservoir. This was confirmed by molecular characterization of the virus (Baxendale et al., 1977; McFerran et al., 1978). 2) The disease is transmitted both vertically and horizontally, with vertical transmission being the primary route of introduction into commercial flocks (McFerran, 1979). 3) Vaccination with inactivated vaccines is highly effective in preventing the disease. Studies have shown that vaccination of pullets at 16-18 weeks of age provides protective immunity and reduces the drop in egg production (Baxendale, 1978; McFerran, 1980). 4) The HI test is a reliable serological test for the diagnosis of EDS-76, and it is widely used in surveillance programs (Adair et al., 1986). 5) The economic impact of EDS-76 is significant, with losses due to reduced egg production and the production of abnormal eggs. A study by van Eck (1980) reported that the disease can cause a 40% drop in egg production, leading to substantial financial losses. 6) Biosecurity measures, including the use of SPF flocks for breeding stock and the control of wild bird contact, are essential for the prevention of the disease (McFerran, 1989). 7) The use of contaminated vaccines has been identified as a source of infection, highlighting the importance of using vaccines from reputable sources (McFerran, 1981). 8) Recent molecular studies have characterized the genome of EDSV, providing insights into its evolution and pathogenesis (Hess et al., 1997; Farkas et al., 2002). Overall, the literature emphasizes the importance of vaccination, biosecurity, and early diagnosis in the control of EDS-76.